Petco Q2 2025 Results: Net Sales Fall 2.3%, GAAP Net Income Rises to $14 Million, Adjusted EBITDA Up to $113.9 Million

Reuters
08/29
Petco <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Results: Net Sales Fall 2.3%, GAAP Net Income Rises to $14 Million, Adjusted EBITDA Up to $113.9 Million

Petco Health and Wellness Company Inc. (Nasdaq: WOOF) announced its second quarter 2025 financial results, reporting a net sales figure of $1.5 billion, a 2.3% decrease year over year, consistent with the company's second quarter outlook. Comparable sales also saw a decline of 1.4% compared to the previous year. Despite the decline in sales, the company's gross profit margin expanded by approximately 120 basis points, reaching 39.3% as a percentage of net sales. Operating income showed a significant improvement, increasing by $40.6 million to $43.0 million. Similarly, GAAP net income improved by $38.8 million to reach $14.0 million. Adjusted EBITDA experienced a rise of $30.3 million, amounting to $113.9 million for the quarter. Petco has raised its earnings outlook for the full year 2025, while maintaining its full-year net sales outlook. The company also provided its outlook for the third quarter of 2025, with assumptions that current economic conditions, tariffs, and other factors remain consistent. CEO Joel Anderson emphasized the company's commitment to executing its objectives and pursuing targeted investments to support sustainable profitable growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Petco Health and Wellness Company Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA60853) on August 28, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10